CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cameron, J. E.
Right arrow Articles by Hagensee, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cameron, J. E.
Right arrow Articles by Hagensee, M. E.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, May 2003, p. 431-438, Vol. 10, No. 3
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.3.431-438.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Human Papillomavirus-Specific Antibody Status in Oral Fluids Modestly Reflects Serum Status in Human Immunodeficiency Virus-Positive Individuals

Jennifer E. Cameron,1 Isaac V. Snowhite,1 Anil K. Chaturvedi,2 and Michael E. Hagensee1,3,4*

Department of Microbiology, Immunology, and Parasitology,1 Department of Medicine,3 Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center,4 Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana2

Received 6 August 2002/ Returned for modification 26 November 2002/ Accepted 22 January 2003

Serological assays are valuable tools for studies of the epidemiology of human papillomaviruses (HPVs). The efficacy of a less invasive oral-fluid assay for detection of HPV antibodies was examined. Matched serum, saliva, and oral mucosal transudate (OMT) specimens collected from 150 human immunodeficiency virus-seropositive patients were tested for immunoglobulin G antibodies against HPV-6 and HPV-11 combined (HPV-6/11) and HPV-16 capsids. Antibodies to HPV were detected in both types of oral specimens. Seroprevalence rates were 55% for HPV-6/11 and 37% for HPV-16, whereas oral prevalence rates were significantly lower (for HPV-6/11 in saliva, 31%, and in OMT, 19%; for HPV-16 in saliva, 19%, and in OMT, 17%). HPV antibody detection in OMT more accurately reflected the presence of antibodies in serum than did HPV antibody detection in saliva. More stringent saliva assay cutpoints yielded stronger associations between oropositivity and seropositivity; less stringent OMT cutpoints yielded stronger associations between oropositivity and seropositivity. Although HPV antibodies were detected in oral fluids, further optimization of the assay is necessary before oral-fluid testing can be implemented as a reliable alternative to serum testing for HPV.


* Corresponding author. Mailing address: Louisiana State University Health Sciences Center, Department of Medicine, Section of Infectious Diseases, 1542 Tulane Ave., New Orleans, LA 70112. Phone: (504) 568-4073. Fax: (504) 568-2918. E-mail: mhagen{at}lsuhsc.edu.


Clinical and Diagnostic Laboratory Immunology, May 2003, p. 431-438, Vol. 10, No. 3
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.3.431-438.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.